Exiqon and Asuragen Sign Agreement for Real-Time PCR Services

News   Jun 11, 2013

 
Exiqon and Asuragen Sign Agreement for Real-Time PCR Services
 
 
 
 

RELATED ARTICLES

Could This Be a "Silver Bullet" for Preventing and Treating Colon Cancer?

News

A team of scientists targeted the gene CtBP with a drug known as HIPP (2-hydroxy-imino phenylpyruvic acid) and were able to reduce the development of pre-cancerous polyps by half.

READ MORE

Programming Cells with Computer-like Logic

News

Novel RNA nano-devices in living cells can sense and analyze multiple complex signals for future synthetic diagnostics and therapeutics.

READ MORE

Understanding the Cellular Systems that Hold Back the Spread of Cancer

News

Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE